Literature DB >> 15985319

Attenuated immune response to tetanus toxoid in young healthy men protected against tetanus.

Elena Danilova1, Alexey Shiryayev, Einar Klaeboe Kristoffersen, Haakon Sjursen.   

Abstract

Tetanus booster is a routine procedure of tetanus prevention in populations with high risk of injury, independent of the levels of protection. But the immune response in already protected individuals is not well studied. We describe the kinetics of booster response in individuals by measuring tetanus antitoxin levels by indirect ELISA. A 6-month follow up was performed on 60 boosted individuals tested before, 1 week, 1, 2, 3 and 6 months after the booster. High initial protection (mean titer 1.08 IU/ml) and less than 3-fold increase after 1 month were observed. After 1 month of stable antitoxin levels, the levels slowly decreased and reached a mean titer of 1.78 IU/ml after 6 months. Individuals with initial levels <1 IU/ml had booster response after the first month twice as high compared to those with initial level >or=1 IU/ml. However, in both groups, the decline from 1 to 6 months was about 2-fold. Individuals already protected against tetanus exhibited an attenuated, short-lasting booster response to tetanus toxoid. This was more pronounced in individuals with pre-booster levels >or=1 IU/ml, who did not improve immune protection after the booster.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985319     DOI: 10.1016/j.vaccine.2005.05.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Quantitative analysis of levels of serum immunoglobulin G against botulinum neurotoxin type D and association with protection in natural outbreaks of cattle botulism.

Authors:  A Steinman; M Chaffer; D Elad; N Y Shpigel
Journal:  Clin Vaccine Immunol       Date:  2006-08

2.  Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.

Authors:  Maheshi N Ramasamy; Elizabeth A Clutterbuck; Kathryn Haworth; Jaclyn Bowman; Omar Omar; Amber J Thompson; Geraldine Blanchard-Rohner; Ly-Mee Yu; Matthew D Snape; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2014-06-25

3.  Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.

Authors:  Anita H J van den Biggelaar; Peter C Richmond; Angela Fuery; Denise Anderson; Christine Opa; Gerard Saleu; Mildred Lai; Jacinta P Francis; Michael P Alpers; William S Pomat; Deborah Lehmann
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.